Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT)

Q: What does CUSIP 097702203 represent in this 13F holders report?

CUSIP 097702203 is the security identifier for BOLT - Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share used to aggregate holder disclosures.

Q: How many institutions held BOLT - Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share in Q1 2026?

24 institutional investors reported BOLT - Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share for Q1 2026. Use the holders table for investor-level position and value details.

CUSIP: 097702203

Q1 2026 13F Holders as of 31 Mar 2026

Security type / class: Equity / Common Stock, par value $0.00001 per share
Total 13F shares: 613,252
Total 13F value: $2,488,203
Share change: +10,714
SEC-reported price per share: $4.04
Number of holders: 24
Value change: +$42,876
Number of buys: 9
Number of sells: 5
Shares outstanding: 2,356,663

Security key

097702203

Report period

Q1 2026

Institutions

Top holders

BOLT full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2026 Previous quarter: Q4 2025 Bolt Biotherapeutics, Inc. SEC filings Bolt Biotherapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 097702203

Newer quarter: Q2 2026 Previous quarter: Q4 2025

Recent filing periods:

Q3 2026 Q2 2026 Q1 2026 Q4 2025 Q3 2025

Ownership snapshot

Top reported holders of BOLT - Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Pivotal bioVenture Partne...

Disclosed value leader

Vivo Capital VIII, LLC

Comparable rows

2/15

Latest evidence

24 Feb 2026

13D/G 3/4/5 13F Lead comparable stake: 4.6% 13 rows are not safely comparable across share classes. 13D/G row: Pivotal bioVenture Partners Fund I, L.P. Showing 1-6 of 15 holder rows.

Quick read

Pivotal bioVenture Partners Fund I, L.P. leads the comparable SEC ownership view at 4.6%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Pivotal bioVenture Partners Fund I, L.P.'s linked filing trail.

Comparable ownership Top 2

Pivotal bioVenture Partners Fund ... 4.6%

TANG CAPITAL MANAGEMENT LLC 3.5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Pivotal bioVenture Partners Fund I, L.P.	13D/G Nan Fung Group Holdings Limited 13D/G	4.6% Reported 13D/G · 24 Feb 2026	$478,373 87,486 shares	-$222,181	24 Feb 2026
TANG CAPITAL MANAGEMENT LLC	13D/G 13D/G	3.5% Reported 13D/G · 30 Sep 2025	$355,790 66,879 shares	-$531,990	30 Sep 2025
Vivo Capital VIII, LLC	3/4/5 10%+ Owner 3/4/5	— mixed-class rows	$5,435,517 5,763,311 shares mixed-class rows	—	21 Nov 2023
Novo Holdings A/S	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$3,518,791 3,703,991 shares	—	13 Jul 2022
Edgar Engleman	3/4/5 Director 3/4/5	— mixed-class rows	$1,969,355 2,098,005 shares mixed-class rows	—	29 Nov 2023
Sofinnova Investments, Inc.	13F Company 13F	— denominator unverified	$753,058 137,721 shares	—	31 Dec 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

613,252

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2026 vs Q4 2025 Across Filers

Q4 2025 holders

Q1 2026 holders

Holder diff

Investor	Q4 2025 Shares	Q1 2026 Shares	Share Diff	Share Chg %	Q4 2025 value	Q1 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend